1. Home
  2. OCUL vs AAT Comparison

OCUL vs AAT Comparison

Compare OCUL & AAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • AAT
  • Stock Information
  • Founded
  • OCUL 2006
  • AAT 1967
  • Country
  • OCUL United States
  • AAT United States
  • Employees
  • OCUL N/A
  • AAT N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • AAT Real Estate Investment Trusts
  • Sector
  • OCUL Health Care
  • AAT Real Estate
  • Exchange
  • OCUL Nasdaq
  • AAT Nasdaq
  • Market Cap
  • OCUL 1.4B
  • AAT 1.6B
  • IPO Year
  • OCUL 2014
  • AAT 2011
  • Fundamental
  • Price
  • OCUL $8.01
  • AAT $24.81
  • Analyst Decision
  • OCUL Strong Buy
  • AAT Hold
  • Analyst Count
  • OCUL 8
  • AAT 2
  • Target Price
  • OCUL $16.50
  • AAT $26.00
  • AVG Volume (30 Days)
  • OCUL 874.8K
  • AAT 336.1K
  • Earning Date
  • OCUL 03-10-2025
  • AAT 02-04-2025
  • Dividend Yield
  • OCUL N/A
  • AAT 5.40%
  • EPS Growth
  • OCUL N/A
  • AAT 17.42
  • EPS
  • OCUL N/A
  • AAT 0.97
  • Revenue
  • OCUL $61,442,000.00
  • AAT $452,499,000.00
  • Revenue This Year
  • OCUL $11.40
  • AAT N/A
  • Revenue Next Year
  • OCUL $13.58
  • AAT $4.31
  • P/E Ratio
  • OCUL N/A
  • AAT $25.65
  • Revenue Growth
  • OCUL 6.45
  • AAT 5.13
  • 52 Week Low
  • OCUL $3.76
  • AAT $20.03
  • 52 Week High
  • OCUL $11.78
  • AAT $29.15
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 38.27
  • AAT 41.38
  • Support Level
  • OCUL $7.99
  • AAT $24.44
  • Resistance Level
  • OCUL $8.43
  • AAT $25.36
  • Average True Range (ATR)
  • OCUL 0.38
  • AAT 0.55
  • MACD
  • OCUL -0.03
  • AAT -0.02
  • Stochastic Oscillator
  • OCUL 20.66
  • AAT 48.65

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About AAT American Assets Trust Inc.

American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.

Share on Social Networks: